Skip to Content
Merck
CN

[Antihypoxants: their status and outlook].

Eksperimental'naia i klinicheskaia farmakologiia (1998-10-23)
V D Luk'ianchuk, L V Savchenkova
ABSTRACT

The survey deals with the up-to-date information in the literature on the problem of pharmacological correction of pathological changes found in the organism in the hypoxic syndrome. The principal approaches to pharmacotherapy of this pathological condition are pointed out. Information on the up-to-date and effective antihypoxia agents applied in medical practice and those in the stage of development is given.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2-Imino-4-thiobiuret, 99%